Mydecine Innovations Group Inc. announced a non-brokered private placement to issue 55,555,555 common shares at an issue price of CAD 0.018 per share for the gross proceeds of CAD 999,999.99 on May 1, 2024. The transaction will include participation from individual investor Josh Bartch, an insider of the Company. All securities issuable under the Private Placement will be subject to a statutory hold period lasting four months and one day following the closing of the Private Placement. No finders? fees are payable under the proposed Private Placement. The Private Placement will be
subject to shareholder approval at the Meeting